| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.31 | 0.004 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |